Clinical trials
Obesity trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
181 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 6 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2020 | 5 |
| 2021 | 11 |
| 2022 | 6 |
| 2023 | 14 |
| 2024 | 15 |
| 2025 | 25 |
| 2026 | 35 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 86 |
| Recruiting | 35 |
| Unknown status | 18 |
| Not yet recruiting | 16 |
| Active, not recruiting | 15 |
| Terminated | 9 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 23 |
| Eli Lilly and Company | 13 |
| University of Adelaide | 9 |
| Amgen | 7 |
| Zafgen, Inc. | 7 |
| University of Melbourne | 6 |
| University of Sydney | 6 |
| AstraZeneca | 5 |
| Boehringer Ingelheim | 5 |
| Sanofi | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 181 |
| Overweight | 75 |
| Diabetes Mellitus, Type 2 | 27 |
| Cardiovascular Diseases | 9 |
| Insulin Resistance | 9 |
| Sleep Apnea, Obstructive | 9 |
| Weight Loss | 8 |
| Osteoarthritis, Knee | 6 |
| Diabetes Mellitus | 5 |
| Inflammation | 5 |
Trials
Showing 76 to 100 of 181. Each trial links to its page on Pharma Observatory.
81 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.